Search results
Bristol Myers' schizophrenia drug reduces symptoms without weight gain in late-stage studies
Reuters via AOL· 3 months agoBristol Myers Squibb said on Saturday data from late-stage studies of its experimental schizophrenia...
New study solves riddle of how dopamine relates to schizophrenia
Press Association News via AOL· 2 years agoResearchers believe they have solved a riddle that has challenged scientists for more than 70 years...
FDA Accepts Karuna's (KRTX) NDA Filing for Schizophrenia Drug
Zacks via Yahoo Finance· 7 months agoIf approved, Karuna's (KRTX) KarXT will be the first new mechanism of action to treat schizophrenia...
Karuna's (KRTX) KarXT Meets Primary Goal in Schizophrenia Study
Zacks via Yahoo Finance· 1 year agoData from a late-stage study shows that treatment with Karuna's (KRTX) lead candidate, KarXT, led to...
65 days without schizophrenia meds in Milwaukee County Jail leads to County paying $1M settlement
Milwaukee Journal Sentinel via Yahoo News· 9 months agoMilwaukee County Jail staff failed to give Omar Wesley schizophrenia medication 65 days over a six...
What Do Anticholinergic Drugs Do?
Verywell Health via Yahoo News· 3 months agoSymptom improvement comes from blocking the neurotransmitter acetylcholine Medically reviewed by Kathleen Daly, MD Anticholinergic drugs block the action...
Weight-loss medications captured Americans' attention in 2023
United Press International via Yahoo News· 6 months agoEven in a year that saw new drugs for Alzheimer's disease and cancer greenlighted for use in the...
Placebos can ease certain mental disorders, study finds
CNN via Yahoo News· 4 weeks agoGet inspired by a weekly roundup on living well, made simple. Sign up for CNN’s Life, But Better...
Biogen's Quarterly Report Was 'Fine' — Here's Why Shares Toppled
Investor's Business Daily· 2 years agoBiogen's second-quarter report was "fine," according to one analyst. But without an update on its...
Bristol Myers to buy schizophrenia drugmaker Karuna Therapeutics for $14 billion
Reuters via AOL· 6 months ago(Reuters) -Bristol Myers Squibb on Friday agreed to buy Karuna Therapeutics for $14 billion, gaining...
